BioNTech SE (BNTX)

BioNTech SE (BNTX) Stock Price & Analysis


BNTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$95.50 - $188.99
Previous Close$108.64
Average Volume (3M)685.91K
Market Cap
Enterprise Value$12.53B
Total Cash (Recent Filing)$13.88B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)5.9
Nov 06, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)18.33
Shares Outstanding240,993,998
10 Day Avg. Volume497,521
30 Day Avg. Volume685,911
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)1.28
Price to Sales (P/S)1.51
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.31
Enterprise Value/Gross Profit0.88
Enterprise Value/Ebitda1.69
Price Target Upside25.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was BioNTech SE’s price range in the past 12 months?
BioNTech SE lowest stock price was $95.50 and its highest was $188.99 in the past 12 months.
    What is BioNTech SE’s market cap?
    Currently, no data Available
    When is BioNTech SE’s upcoming earnings report date?
    BioNTech SE’s upcoming earnings report date is Nov 06, 2023 which is in 33 days.
      How were BioNTech SE’s earnings last quarter?
      BioNTech SE released its earnings results on Aug 07, 2023. The company reported -$0.835 earnings per share for the quarter, beating the consensus estimate of -$0.88 by $0.045.
        Is BioNTech SE overvalued?
        According to Wall Street analysts BioNTech SE’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does BioNTech SE pay dividends?
          BioNTech SE pays a Notavailable dividend of $1.53 which represents an annual dividend yield of N/A. See more information on BioNTech SE dividends here
            What is BioNTech SE’s EPS estimate?
            BioNTech SE’s EPS estimate is $0.94.
              How many shares outstanding does BioNTech SE have?
              BioNTech SE has 243,019,210 shares outstanding.
                What happened to BioNTech SE’s price movement after its last earnings report?
                BioNTech SE reported an EPS of -$0.835 in its last earnings report, beating expectations of -$0.88. Following the earnings report the stock price went down -7.494%.
                  Which hedge fund is a major shareholder of BioNTech SE?
                  Among the largest hedge funds holding BioNTech SE’s share is PRIMECAP Management Co. It holds BioNTech SE’s shares valued at 503M.


                    BioNTech SE Stock Smart Score

                    The BioNTech SE stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    BioNTech SE

                    BioNTech SE is a Germany-based biotechnology company that develops and manufactures immunotherapies for cancer, infectious diseases, allergies and autoimmune disorders.


                    Top 5 ETFs holding BNTX

                    Market Value
                    Smart Score
                    Fidelity Nasdaq Composite Index ETF
                    Invesco RAFI Strategic US ETF
                    Invesco S&P World Health Care ESG UCITS ETF AccumUSD
                    Up to five ETFs with an Outperform Smart Score that hold BNTX. The ETFs are listed according to market value of BNTX within the ETF

                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis